Global Solid Dosage Form Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Solid Dosage Form Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report is a detailed and comprehensive analysis for global Solid Dosage Form Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Solid Dosage Form Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Solid Dosage Form Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Solid Dosage Form Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Solid Dosage Form Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Solid Dosage Form Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Solid Dosage Form Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie and Merck & Co., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Solid Dosage Form Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Solid Dosage Form Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Solid Dosage Form Drug, with revenue, gross margin and global market share of Solid Dosage Form Drug from 2018 to 2023.
Chapter 3, the Solid Dosage Form Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Solid Dosage Form Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Solid Dosage Form Drug.
Chapter 13, to describe Solid Dosage Form Drug research findings and conclusion.
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report is a detailed and comprehensive analysis for global Solid Dosage Form Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Solid Dosage Form Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Solid Dosage Form Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Solid Dosage Form Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Solid Dosage Form Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Solid Dosage Form Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Solid Dosage Form Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie and Merck & Co., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Solid Dosage Form Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tablet
- Capsules
- Other
- Hospital
- Retail Pharmacy
- Other
- Johnson & Johnson
- Novartis
- Roche
- AbbVie
- Merck & Co.
- Bristol Myers Squibb
- GlaxoSmithKline
- Pfizer
- Sanofi
- Takeda
- AstraZeneca
- Bayer
- Eli Lilly & Co.
- Gilead Sciences
- Amgen
- Teva
- Boehringer Ingelheim
- Biogen
- Astellas
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Solid Dosage Form Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Solid Dosage Form Drug, with revenue, gross margin and global market share of Solid Dosage Form Drug from 2018 to 2023.
Chapter 3, the Solid Dosage Form Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Solid Dosage Form Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Solid Dosage Form Drug.
Chapter 13, to describe Solid Dosage Form Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Solid Dosage Form Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Solid Dosage Form Drug by Type
1.3.1 Overview: Global Solid Dosage Form Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Solid Dosage Form Drug Consumption Value Market Share by Type in 2022
1.3.3 Tablet
1.3.4 Capsules
1.3.5 Other
1.4 Global Solid Dosage Form Drug Market by Application
1.4.1 Overview: Global Solid Dosage Form Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Solid Dosage Form Drug Market Size & Forecast
1.6 Global Solid Dosage Form Drug Market Size and Forecast by Region
1.6.1 Global Solid Dosage Form Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Solid Dosage Form Drug Market Size by Region, (2018-2029)
1.6.3 North America Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.6 South America Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Solid Dosage Form Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Solid Dosage Form Drug Product and Solutions
2.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Solid Dosage Form Drug Product and Solutions
2.2.4 Novartis Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Solid Dosage Form Drug Product and Solutions
2.3.4 Roche Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Solid Dosage Form Drug Product and Solutions
2.4.4 AbbVie Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 Merck & Co.
2.5.1 Merck & Co. Details
2.5.2 Merck & Co. Major Business
2.5.3 Merck & Co. Solid Dosage Form Drug Product and Solutions
2.5.4 Merck & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck & Co. Recent Developments and Future Plans
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Solid Dosage Form Drug Product and Solutions
2.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Solid Dosage Form Drug Product and Solutions
2.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Solid Dosage Form Drug Product and Solutions
2.8.4 Pfizer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Solid Dosage Form Drug Product and Solutions
2.9.4 Sanofi Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Solid Dosage Form Drug Product and Solutions
2.10.4 Takeda Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Solid Dosage Form Drug Product and Solutions
2.11.4 AstraZeneca Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AstraZeneca Recent Developments and Future Plans
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business
2.12.3 Bayer Solid Dosage Form Drug Product and Solutions
2.12.4 Bayer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bayer Recent Developments and Future Plans
2.13 Eli Lilly & Co.
2.13.1 Eli Lilly & Co. Details
2.13.2 Eli Lilly & Co. Major Business
2.13.3 Eli Lilly & Co. Solid Dosage Form Drug Product and Solutions
2.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Eli Lilly & Co. Recent Developments and Future Plans
2.14 Gilead Sciences
2.14.1 Gilead Sciences Details
2.14.2 Gilead Sciences Major Business
2.14.3 Gilead Sciences Solid Dosage Form Drug Product and Solutions
2.14.4 Gilead Sciences Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Gilead Sciences Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Solid Dosage Form Drug Product and Solutions
2.15.4 Amgen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amgen Recent Developments and Future Plans
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva Solid Dosage Form Drug Product and Solutions
2.16.4 Teva Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Teva Recent Developments and Future Plans
2.17 Boehringer Ingelheim
2.17.1 Boehringer Ingelheim Details
2.17.2 Boehringer Ingelheim Major Business
2.17.3 Boehringer Ingelheim Solid Dosage Form Drug Product and Solutions
2.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Boehringer Ingelheim Recent Developments and Future Plans
2.18 Biogen
2.18.1 Biogen Details
2.18.2 Biogen Major Business
2.18.3 Biogen Solid Dosage Form Drug Product and Solutions
2.18.4 Biogen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Biogen Recent Developments and Future Plans
2.19 Astellas
2.19.1 Astellas Details
2.19.2 Astellas Major Business
2.19.3 Astellas Solid Dosage Form Drug Product and Solutions
2.19.4 Astellas Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Astellas Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Solid Dosage Form Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Solid Dosage Form Drug by Company Revenue
3.2.2 Top 3 Solid Dosage Form Drug Players Market Share in 2022
3.2.3 Top 6 Solid Dosage Form Drug Players Market Share in 2022
3.3 Solid Dosage Form Drug Market: Overall Company Footprint Analysis
3.3.1 Solid Dosage Form Drug Market: Region Footprint
3.3.2 Solid Dosage Form Drug Market: Company Product Type Footprint
3.3.3 Solid Dosage Form Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Solid Dosage Form Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Solid Dosage Form Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Solid Dosage Form Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Solid Dosage Form Drug Consumption Value by Type (2018-2029)
6.2 North America Solid Dosage Form Drug Consumption Value by Application (2018-2029)
6.3 North America Solid Dosage Form Drug Market Size by Country
6.3.1 North America Solid Dosage Form Drug Consumption Value by Country (2018-2029)
6.3.2 United States Solid Dosage Form Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Solid Dosage Form Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Solid Dosage Form Drug Consumption Value by Type (2018-2029)
7.2 Europe Solid Dosage Form Drug Consumption Value by Application (2018-2029)
7.3 Europe Solid Dosage Form Drug Market Size by Country
7.3.1 Europe Solid Dosage Form Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.3 France Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Solid Dosage Form Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Solid Dosage Form Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Solid Dosage Form Drug Market Size by Region
8.3.1 Asia-Pacific Solid Dosage Form Drug Consumption Value by Region (2018-2029)
8.3.2 China Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.5 India Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Solid Dosage Form Drug Consumption Value by Type (2018-2029)
9.2 South America Solid Dosage Form Drug Consumption Value by Application (2018-2029)
9.3 South America Solid Dosage Form Drug Market Size by Country
9.3.1 South America Solid Dosage Form Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Solid Dosage Form Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Solid Dosage Form Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Solid Dosage Form Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Solid Dosage Form Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Solid Dosage Form Drug Market Size by Country
10.3.1 Middle East & Africa Solid Dosage Form Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Solid Dosage Form Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Solid Dosage Form Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Solid Dosage Form Drug Market Drivers
11.2 Solid Dosage Form Drug Market Restraints
11.3 Solid Dosage Form Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Solid Dosage Form Drug Industry Chain
12.2 Solid Dosage Form Drug Upstream Analysis
12.3 Solid Dosage Form Drug Midstream Analysis
12.4 Solid Dosage Form Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Solid Dosage Form Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Solid Dosage Form Drug by Type
1.3.1 Overview: Global Solid Dosage Form Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Solid Dosage Form Drug Consumption Value Market Share by Type in 2022
1.3.3 Tablet
1.3.4 Capsules
1.3.5 Other
1.4 Global Solid Dosage Form Drug Market by Application
1.4.1 Overview: Global Solid Dosage Form Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Solid Dosage Form Drug Market Size & Forecast
1.6 Global Solid Dosage Form Drug Market Size and Forecast by Region
1.6.1 Global Solid Dosage Form Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Solid Dosage Form Drug Market Size by Region, (2018-2029)
1.6.3 North America Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.6 South America Solid Dosage Form Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Solid Dosage Form Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Solid Dosage Form Drug Product and Solutions
2.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Solid Dosage Form Drug Product and Solutions
2.2.4 Novartis Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Solid Dosage Form Drug Product and Solutions
2.3.4 Roche Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Solid Dosage Form Drug Product and Solutions
2.4.4 AbbVie Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 Merck & Co.
2.5.1 Merck & Co. Details
2.5.2 Merck & Co. Major Business
2.5.3 Merck & Co. Solid Dosage Form Drug Product and Solutions
2.5.4 Merck & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck & Co. Recent Developments and Future Plans
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Solid Dosage Form Drug Product and Solutions
2.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Solid Dosage Form Drug Product and Solutions
2.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Solid Dosage Form Drug Product and Solutions
2.8.4 Pfizer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Solid Dosage Form Drug Product and Solutions
2.9.4 Sanofi Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Solid Dosage Form Drug Product and Solutions
2.10.4 Takeda Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Solid Dosage Form Drug Product and Solutions
2.11.4 AstraZeneca Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AstraZeneca Recent Developments and Future Plans
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business
2.12.3 Bayer Solid Dosage Form Drug Product and Solutions
2.12.4 Bayer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bayer Recent Developments and Future Plans
2.13 Eli Lilly & Co.
2.13.1 Eli Lilly & Co. Details
2.13.2 Eli Lilly & Co. Major Business
2.13.3 Eli Lilly & Co. Solid Dosage Form Drug Product and Solutions
2.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Eli Lilly & Co. Recent Developments and Future Plans
2.14 Gilead Sciences
2.14.1 Gilead Sciences Details
2.14.2 Gilead Sciences Major Business
2.14.3 Gilead Sciences Solid Dosage Form Drug Product and Solutions
2.14.4 Gilead Sciences Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Gilead Sciences Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Solid Dosage Form Drug Product and Solutions
2.15.4 Amgen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amgen Recent Developments and Future Plans
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva Solid Dosage Form Drug Product and Solutions
2.16.4 Teva Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Teva Recent Developments and Future Plans
2.17 Boehringer Ingelheim
2.17.1 Boehringer Ingelheim Details
2.17.2 Boehringer Ingelheim Major Business
2.17.3 Boehringer Ingelheim Solid Dosage Form Drug Product and Solutions
2.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Boehringer Ingelheim Recent Developments and Future Plans
2.18 Biogen
2.18.1 Biogen Details
2.18.2 Biogen Major Business
2.18.3 Biogen Solid Dosage Form Drug Product and Solutions
2.18.4 Biogen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Biogen Recent Developments and Future Plans
2.19 Astellas
2.19.1 Astellas Details
2.19.2 Astellas Major Business
2.19.3 Astellas Solid Dosage Form Drug Product and Solutions
2.19.4 Astellas Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Astellas Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Solid Dosage Form Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Solid Dosage Form Drug by Company Revenue
3.2.2 Top 3 Solid Dosage Form Drug Players Market Share in 2022
3.2.3 Top 6 Solid Dosage Form Drug Players Market Share in 2022
3.3 Solid Dosage Form Drug Market: Overall Company Footprint Analysis
3.3.1 Solid Dosage Form Drug Market: Region Footprint
3.3.2 Solid Dosage Form Drug Market: Company Product Type Footprint
3.3.3 Solid Dosage Form Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Solid Dosage Form Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Solid Dosage Form Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Solid Dosage Form Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Solid Dosage Form Drug Consumption Value by Type (2018-2029)
6.2 North America Solid Dosage Form Drug Consumption Value by Application (2018-2029)
6.3 North America Solid Dosage Form Drug Market Size by Country
6.3.1 North America Solid Dosage Form Drug Consumption Value by Country (2018-2029)
6.3.2 United States Solid Dosage Form Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Solid Dosage Form Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Solid Dosage Form Drug Consumption Value by Type (2018-2029)
7.2 Europe Solid Dosage Form Drug Consumption Value by Application (2018-2029)
7.3 Europe Solid Dosage Form Drug Market Size by Country
7.3.1 Europe Solid Dosage Form Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.3 France Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Solid Dosage Form Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Solid Dosage Form Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Solid Dosage Form Drug Market Size by Region
8.3.1 Asia-Pacific Solid Dosage Form Drug Consumption Value by Region (2018-2029)
8.3.2 China Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.5 India Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Solid Dosage Form Drug Consumption Value by Type (2018-2029)
9.2 South America Solid Dosage Form Drug Consumption Value by Application (2018-2029)
9.3 South America Solid Dosage Form Drug Market Size by Country
9.3.1 South America Solid Dosage Form Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Solid Dosage Form Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Solid Dosage Form Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Solid Dosage Form Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Solid Dosage Form Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Solid Dosage Form Drug Market Size by Country
10.3.1 Middle East & Africa Solid Dosage Form Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Solid Dosage Form Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Solid Dosage Form Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Solid Dosage Form Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Solid Dosage Form Drug Market Drivers
11.2 Solid Dosage Form Drug Market Restraints
11.3 Solid Dosage Form Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Solid Dosage Form Drug Industry Chain
12.2 Solid Dosage Form Drug Upstream Analysis
12.3 Solid Dosage Form Drug Midstream Analysis
12.4 Solid Dosage Form Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Solid Dosage Form Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Solid Dosage Form Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Solid Dosage Form Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Solid Dosage Form Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Solid Dosage Form Drug Product and Solutions
Table 8. Johnson & Johnson Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Solid Dosage Form Drug Product and Solutions
Table 13. Novartis Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Solid Dosage Form Drug Product and Solutions
Table 18. Roche Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Roche Recent Developments and Future Plans
Table 20. AbbVie Company Information, Head Office, and Major Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Solid Dosage Form Drug Product and Solutions
Table 23. AbbVie Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AbbVie Recent Developments and Future Plans
Table 25. Merck & Co. Company Information, Head Office, and Major Competitors
Table 26. Merck & Co. Major Business
Table 27. Merck & Co. Solid Dosage Form Drug Product and Solutions
Table 28. Merck & Co. Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Merck & Co. Recent Developments and Future Plans
Table 30. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 31. Bristol Myers Squibb Major Business
Table 32. Bristol Myers Squibb Solid Dosage Form Drug Product and Solutions
Table 33. Bristol Myers Squibb Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bristol Myers Squibb Recent Developments and Future Plans
Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Solid Dosage Form Drug Product and Solutions
Table 38. GlaxoSmithKline Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GlaxoSmithKline Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Solid Dosage Form Drug Product and Solutions
Table 43. Pfizer Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Sanofi Company Information, Head Office, and Major Competitors
Table 46. Sanofi Major Business
Table 47. Sanofi Solid Dosage Form Drug Product and Solutions
Table 48. Sanofi Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sanofi Recent Developments and Future Plans
Table 50. Takeda Company Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Solid Dosage Form Drug Product and Solutions
Table 53. Takeda Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Recent Developments and Future Plans
Table 55. AstraZeneca Company Information, Head Office, and Major Competitors
Table 56. AstraZeneca Major Business
Table 57. AstraZeneca Solid Dosage Form Drug Product and Solutions
Table 58. AstraZeneca Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. AstraZeneca Recent Developments and Future Plans
Table 60. Bayer Company Information, Head Office, and Major Competitors
Table 61. Bayer Major Business
Table 62. Bayer Solid Dosage Form Drug Product and Solutions
Table 63. Bayer Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Bayer Recent Developments and Future Plans
Table 65. Eli Lilly & Co. Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly & Co. Major Business
Table 67. Eli Lilly & Co. Solid Dosage Form Drug Product and Solutions
Table 68. Eli Lilly & Co. Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly & Co. Recent Developments and Future Plans
Table 70. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 71. Gilead Sciences Major Business
Table 72. Gilead Sciences Solid Dosage Form Drug Product and Solutions
Table 73. Gilead Sciences Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Gilead Sciences Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Solid Dosage Form Drug Product and Solutions
Table 78. Amgen Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Teva Company Information, Head Office, and Major Competitors
Table 81. Teva Major Business
Table 82. Teva Solid Dosage Form Drug Product and Solutions
Table 83. Teva Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Teva Recent Developments and Future Plans
Table 85. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 86. Boehringer Ingelheim Major Business
Table 87. Boehringer Ingelheim Solid Dosage Form Drug Product and Solutions
Table 88. Boehringer Ingelheim Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Boehringer Ingelheim Recent Developments and Future Plans
Table 90. Biogen Company Information, Head Office, and Major Competitors
Table 91. Biogen Major Business
Table 92. Biogen Solid Dosage Form Drug Product and Solutions
Table 93. Biogen Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Biogen Recent Developments and Future Plans
Table 95. Astellas Company Information, Head Office, and Major Competitors
Table 96. Astellas Major Business
Table 97. Astellas Solid Dosage Form Drug Product and Solutions
Table 98. Astellas Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Astellas Recent Developments and Future Plans
Table 100. Global Solid Dosage Form Drug Revenue (USD Million) by Players (2018-2023)
Table 101. Global Solid Dosage Form Drug Revenue Share by Players (2018-2023)
Table 102. Breakdown of Solid Dosage Form Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Solid Dosage Form Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Solid Dosage Form Drug Players
Table 105. Solid Dosage Form Drug Market: Company Product Type Footprint
Table 106. Solid Dosage Form Drug Market: Company Product Application Footprint
Table 107. Solid Dosage Form Drug New Market Entrants and Barriers to Market Entry
Table 108. Solid Dosage Form Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Solid Dosage Form Drug Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Solid Dosage Form Drug Consumption Value Share by Type (2018-2023)
Table 111. Global Solid Dosage Form Drug Consumption Value Forecast by Type (2024-2029)
Table 112. Global Solid Dosage Form Drug Consumption Value by Application (2018-2023)
Table 113. Global Solid Dosage Form Drug Consumption Value Forecast by Application (2024-2029)
Table 114. North America Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Solid Dosage Form Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Solid Dosage Form Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Solid Dosage Form Drug Raw Material
Table 145. Key Suppliers of Solid Dosage Form Drug Raw Materials
Table 1. Global Solid Dosage Form Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Solid Dosage Form Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Solid Dosage Form Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Solid Dosage Form Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Solid Dosage Form Drug Product and Solutions
Table 8. Johnson & Johnson Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Solid Dosage Form Drug Product and Solutions
Table 13. Novartis Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Solid Dosage Form Drug Product and Solutions
Table 18. Roche Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Roche Recent Developments and Future Plans
Table 20. AbbVie Company Information, Head Office, and Major Competitors
Table 21. AbbVie Major Business
Table 22. AbbVie Solid Dosage Form Drug Product and Solutions
Table 23. AbbVie Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AbbVie Recent Developments and Future Plans
Table 25. Merck & Co. Company Information, Head Office, and Major Competitors
Table 26. Merck & Co. Major Business
Table 27. Merck & Co. Solid Dosage Form Drug Product and Solutions
Table 28. Merck & Co. Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Merck & Co. Recent Developments and Future Plans
Table 30. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 31. Bristol Myers Squibb Major Business
Table 32. Bristol Myers Squibb Solid Dosage Form Drug Product and Solutions
Table 33. Bristol Myers Squibb Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bristol Myers Squibb Recent Developments and Future Plans
Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Solid Dosage Form Drug Product and Solutions
Table 38. GlaxoSmithKline Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GlaxoSmithKline Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Solid Dosage Form Drug Product and Solutions
Table 43. Pfizer Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Sanofi Company Information, Head Office, and Major Competitors
Table 46. Sanofi Major Business
Table 47. Sanofi Solid Dosage Form Drug Product and Solutions
Table 48. Sanofi Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sanofi Recent Developments and Future Plans
Table 50. Takeda Company Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Solid Dosage Form Drug Product and Solutions
Table 53. Takeda Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Recent Developments and Future Plans
Table 55. AstraZeneca Company Information, Head Office, and Major Competitors
Table 56. AstraZeneca Major Business
Table 57. AstraZeneca Solid Dosage Form Drug Product and Solutions
Table 58. AstraZeneca Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. AstraZeneca Recent Developments and Future Plans
Table 60. Bayer Company Information, Head Office, and Major Competitors
Table 61. Bayer Major Business
Table 62. Bayer Solid Dosage Form Drug Product and Solutions
Table 63. Bayer Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Bayer Recent Developments and Future Plans
Table 65. Eli Lilly & Co. Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly & Co. Major Business
Table 67. Eli Lilly & Co. Solid Dosage Form Drug Product and Solutions
Table 68. Eli Lilly & Co. Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Eli Lilly & Co. Recent Developments and Future Plans
Table 70. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 71. Gilead Sciences Major Business
Table 72. Gilead Sciences Solid Dosage Form Drug Product and Solutions
Table 73. Gilead Sciences Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Gilead Sciences Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Solid Dosage Form Drug Product and Solutions
Table 78. Amgen Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Teva Company Information, Head Office, and Major Competitors
Table 81. Teva Major Business
Table 82. Teva Solid Dosage Form Drug Product and Solutions
Table 83. Teva Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Teva Recent Developments and Future Plans
Table 85. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 86. Boehringer Ingelheim Major Business
Table 87. Boehringer Ingelheim Solid Dosage Form Drug Product and Solutions
Table 88. Boehringer Ingelheim Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Boehringer Ingelheim Recent Developments and Future Plans
Table 90. Biogen Company Information, Head Office, and Major Competitors
Table 91. Biogen Major Business
Table 92. Biogen Solid Dosage Form Drug Product and Solutions
Table 93. Biogen Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Biogen Recent Developments and Future Plans
Table 95. Astellas Company Information, Head Office, and Major Competitors
Table 96. Astellas Major Business
Table 97. Astellas Solid Dosage Form Drug Product and Solutions
Table 98. Astellas Solid Dosage Form Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Astellas Recent Developments and Future Plans
Table 100. Global Solid Dosage Form Drug Revenue (USD Million) by Players (2018-2023)
Table 101. Global Solid Dosage Form Drug Revenue Share by Players (2018-2023)
Table 102. Breakdown of Solid Dosage Form Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Solid Dosage Form Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Solid Dosage Form Drug Players
Table 105. Solid Dosage Form Drug Market: Company Product Type Footprint
Table 106. Solid Dosage Form Drug Market: Company Product Application Footprint
Table 107. Solid Dosage Form Drug New Market Entrants and Barriers to Market Entry
Table 108. Solid Dosage Form Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Solid Dosage Form Drug Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Solid Dosage Form Drug Consumption Value Share by Type (2018-2023)
Table 111. Global Solid Dosage Form Drug Consumption Value Forecast by Type (2024-2029)
Table 112. Global Solid Dosage Form Drug Consumption Value by Application (2018-2023)
Table 113. Global Solid Dosage Form Drug Consumption Value Forecast by Application (2024-2029)
Table 114. North America Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Solid Dosage Form Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Solid Dosage Form Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Solid Dosage Form Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Solid Dosage Form Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Solid Dosage Form Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Solid Dosage Form Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Solid Dosage Form Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Solid Dosage Form Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Solid Dosage Form Drug Raw Material
Table 145. Key Suppliers of Solid Dosage Form Drug Raw Materials
LIST OF FIGURES
Figure 1. Solid Dosage Form Drug Picture
Figure 2. Global Solid Dosage Form Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Solid Dosage Form Drug Consumption Value Market Share by Type in 2022
Figure 4. Tablet
Figure 5. Capsules
Figure 6. Other
Figure 7. Global Solid Dosage Form Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Solid Dosage Form Drug Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Other Picture
Figure 12. Global Solid Dosage Form Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Solid Dosage Form Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Solid Dosage Form Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Solid Dosage Form Drug Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Solid Dosage Form Drug Consumption Value Market Share by Region in 2022
Figure 17. North America Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Solid Dosage Form Drug Revenue Share by Players in 2022
Figure 23. Solid Dosage Form Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Solid Dosage Form Drug Market Share in 2022
Figure 25. Global Top 6 Players Solid Dosage Form Drug Market Share in 2022
Figure 26. Global Solid Dosage Form Drug Consumption Value Share by Type (2018-2023)
Figure 27. Global Solid Dosage Form Drug Market Share Forecast by Type (2024-2029)
Figure 28. Global Solid Dosage Form Drug Consumption Value Share by Application (2018-2023)
Figure 29. Global Solid Dosage Form Drug Market Share Forecast by Application (2024-2029)
Figure 30. North America Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. France Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Solid Dosage Form Drug Consumption Value Market Share by Region (2018-2029)
Figure 47. China Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. India Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Solid Dosage Form Drug Market Drivers
Figure 65. Solid Dosage Form Drug Market Restraints
Figure 66. Solid Dosage Form Drug Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Solid Dosage Form Drug in 2022
Figure 69. Manufacturing Process Analysis of Solid Dosage Form Drug
Figure 70. Solid Dosage Form Drug Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Solid Dosage Form Drug Picture
Figure 2. Global Solid Dosage Form Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Solid Dosage Form Drug Consumption Value Market Share by Type in 2022
Figure 4. Tablet
Figure 5. Capsules
Figure 6. Other
Figure 7. Global Solid Dosage Form Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Solid Dosage Form Drug Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Other Picture
Figure 12. Global Solid Dosage Form Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Solid Dosage Form Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Solid Dosage Form Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Solid Dosage Form Drug Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Solid Dosage Form Drug Consumption Value Market Share by Region in 2022
Figure 17. North America Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Solid Dosage Form Drug Revenue Share by Players in 2022
Figure 23. Solid Dosage Form Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Solid Dosage Form Drug Market Share in 2022
Figure 25. Global Top 6 Players Solid Dosage Form Drug Market Share in 2022
Figure 26. Global Solid Dosage Form Drug Consumption Value Share by Type (2018-2023)
Figure 27. Global Solid Dosage Form Drug Market Share Forecast by Type (2024-2029)
Figure 28. Global Solid Dosage Form Drug Consumption Value Share by Application (2018-2023)
Figure 29. Global Solid Dosage Form Drug Market Share Forecast by Application (2024-2029)
Figure 30. North America Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. France Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Solid Dosage Form Drug Consumption Value Market Share by Region (2018-2029)
Figure 47. China Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. India Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Solid Dosage Form Drug Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Solid Dosage Form Drug Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Solid Dosage Form Drug Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Solid Dosage Form Drug Market Drivers
Figure 65. Solid Dosage Form Drug Market Restraints
Figure 66. Solid Dosage Form Drug Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Solid Dosage Form Drug in 2022
Figure 69. Manufacturing Process Analysis of Solid Dosage Form Drug
Figure 70. Solid Dosage Form Drug Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
